van Dissel J T, Stikkelbroeck J J, Michel B C, van den Barselaar M T, Leijh P C, van Furth R
J Immunol. 1987 Sep 1;139(5):1673-8.
The effect of recombinant murine interferon-gamma (rIFN-gamma) as single stimulus for the activation of antibacterial activity of macrophages was investigated on the basis of the rate of intracellular killing of Listeria monocytogenes and Salmonella typhimurium by normal and rIFN gamma-activated peritoneal macrophages of CBA and C57BL/10 mice, which differ in natural resistance to infection by these bacteria. Eighteen hours after i.p. injection of 10 to 1 X 10(4) U rIFN-gamma, resident and exudate peritoneal macrophages which had phagocytosed L. monocytogenes or S. typhimurium in vivo, killed both species in vitro just as efficiently as did resident macrophages of normal mice. Similar results were obtained after 18 hr of in vitro incubation of resident or exudate peritoneal macrophages with 0.1 to 1 X 10(4) U/ml rIFN-gamma. Consistent with the in vitro findings, two i.v. injections of 5 X 10(4) U rIFN-gamma did not affect the rate of in vivo proliferation of L. monocytogenes or S. typhimurium in the spleens of mice during the first 2 days after i.v. injection of the bacteria. Compared with the effect on the controls, two i.p. injections of 5 X 10(2) to 5 X 10(4) U rIFN-gamma did not decrease the numbers of viable S. typhimurium in either the peritoneal cell suspension or the spleen 24 hr after i.p. injection of the bacteria. Checking the state of activation of rIFN-gamma-activated macrophages on the basis of two commonly used criteria for macrophage activation showed that rIFN-gamma-activated macrophages inhibited the intracellular replication of Toxoplasma gondii and displayed enhanced O2 consumption and H2O2 release after stimulation with phorbol myristate acetate compared with macrophages from normal CBA and C57BL/10 mice. The present findings show that as single activating stimulus, rIFN-gamma is not capable of activating the antibacterial effector functions of peritoneal macrophages against facultative intracellular pathogens such as L. monocytogenes and S. typhimurium.
基于CBA和C57BL/10小鼠正常及经重组鼠γ干扰素(rIFN-γ)激活的腹腔巨噬细胞对单核细胞增生李斯特菌和鼠伤寒沙门氏菌的细胞内杀伤率,研究了rIFN-γ作为单一刺激物激活巨噬细胞抗菌活性的效果,这两种小鼠对这些细菌感染的天然抵抗力有所不同。腹腔注射10至1×10⁴U rIFN-γ 18小时后,体内吞噬了单核细胞增生李斯特菌或鼠伤寒沙门氏菌的驻留和渗出腹腔巨噬细胞,在体外对这两种菌的杀伤效率与正常小鼠的驻留巨噬细胞相同。用0.1至1×10⁴U/ml rIFN-γ对驻留或渗出腹腔巨噬细胞进行18小时体外孵育后,也得到了类似结果。与体外研究结果一致,静脉注射两次5×10⁴U rIFN-γ对静脉注射细菌后前两天小鼠脾脏中单核细胞增生李斯特菌或鼠伤寒沙门氏菌的体内增殖率没有影响。与对照组相比,腹腔注射两次5×10²至5×10⁴U rIFN-γ在腹腔注射细菌24小时后,并没有减少腹腔细胞悬液或脾脏中活的鼠伤寒沙门氏菌数量。根据两种常用的巨噬细胞激活标准检查rIFN-γ激活的巨噬细胞的激活状态,结果显示,与正常CBA和C57BL/10小鼠的巨噬细胞相比,rIFN-γ激活的巨噬细胞抑制了刚地弓形虫的细胞内复制,并且在用佛波酯肉豆蔻酸酯刺激后表现出增强的耗氧量和过氧化氢释放。目前的研究结果表明,作为单一激活刺激物,rIFN-γ不能激活腹腔巨噬细胞针对兼性细胞内病原体(如单核细胞增生李斯特菌和鼠伤寒沙门氏菌)的抗菌效应功能。